Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 22018D0441

    Decision of the EEA Joint Committee No 183/2016 of 23 September 2016 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2018/441]

    OJ L 80, 22.3.2018, p. 27–28 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

    Legal status of the document In force

    ELI: http://data.europa.eu/eli/dec/2018/441/oj

    22.3.2018   

    EN

    Official Journal of the European Union

    L 80/27


    DECISION OF THE EEA JOINT COMMITTEE

    No 183/2016

    of 23 September 2016

    amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2018/441]

    THE EEA JOINT COMMITTEE,

    Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,

    Whereas:

    (1)

    Commission Implementing Regulation (EU) 2016/636 of 22 April 2016 withdrawing the approval of the active substance Z, Z,Z, Z-7,13,16,19-docosatetraen-1-yl isobutyrate, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (1) is to be incorporated into the EEA Agreement.

    (2)

    Commission Implementing Regulation (EU) 2016/638 of 22 April 2016 withdrawing the approval of the active substance Z-13-hexadecen-11-yn-1-yl acetate, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (2) is to be incorporated into the EEA Agreement.

    (3)

    Annex II to the EEA Agreement should therefore be amended accordingly,

    HAS ADOPTED THIS DECISION:

    Article 1

    Chapter XV of Annex II to the EEA Agreement shall be amended as follows:

    (1)

    the following indents are added to point 13a (Commission Implementing Regulation (EU) No 540/2011):

    ‘—

    32016 R 0636: Commission Implementing Regulation (EU) 2016/636 of 22 April 2016 (OJ L 108, 23.4.2016, p. 22),

    32016 R 0638: Commission Implementing Regulation (EU) 2016/638 of 22 April 2016 (OJ L 108, 23.4.2016, p. 28).’;

    (2)

    the following points are inserted after point 13zzzzzzb (Commission Implementing Regulation (EU) 2016/389):

    ‘13zzzzzzc.

    32016 R 0636: Commission Implementing Regulation (EU) 2016/636 of 22 April 2016 withdrawing the approval of the active substance Z, Z,Z, Z-7,13,16,19-docosatetraen-1-yl isobutyrate, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L 108, 23.4.2016, p. 22).

    13zzzzzzd.

    32016 R 0638: Commission Implementing Regulation (EU) 2016/638 of 22 April 2016 withdrawing the approval of the active substance Z-13-hexadecen-11-yn-1-yl acetate, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L 108, 23.4.2016, p. 28).’

    Article 2

    The texts of Implementing Regulations (EU) 2016/636 and (EU) 2016/638 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

    Article 3

    This Decision shall enter into force on 24 September 2016, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).

    Article 4

    This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

    Done at Brussels, 23 September 2016.

    For the EEA Joint Committee

    The President

    Bergdís ELLERTSDÓTTIR


    (1)   OJ L 108, 23.4.2016, p. 22.

    (2)   OJ L 108, 23.4.2016, p. 28.

    (*1)  No constitutional requirements indicated.


    Top